The Latest Breaking News from HCA Healthcare

RBC Capital Market reduced the target price for HCA Healthcare Inc (NYSE:HCA) from $291 to $267 (26.5% upside), noting the shares were well oversold on Friday (-22%) after a ~5.5% guide-down on known labor headwinds.  The analysts continue to view the labor backdrop as largely transitory and believe HCA management is well equipped to…

Within the last quarter, HCA Healthcare (NYSE:HCA) has observed the following analyst ratings:

Upgrades

Due to concerns over the possibility of aggressive interest rate increases and the consequences of a prolonged Ukraine-Russia war, current market volatility has caused many quality stocks to trade at attractive valuations. For example, fundamentally sound stocks Lockheed Martin (LMT), HCA Healthcare (HCA), FedEx (FDX), Enterprise Products (EPD), and Walgreens…

Hospital operator HCA Healthcare offers relative inflation safety as Covid fades. The IBD Stock Of The Day is near buy points.

HCA Healthcare is the IBD Stock Of The Day. The hospital operator offers multiple buying opportunities as the omicron Covid-19 variant wave recedes. HCA stock rose Wednesday.

Crude oil futures surged over 4% on Tuesday amid concerns about possible supply disruptions due to rising tensions between Russia and Ukraine. Investors, meanwhile, focused on some notable insider trades.

BMO Capital has lowered the price target on HCA Healthcare Inc (NYSE: HCA) to $250 f

Analysts have provided the following ratings for HCA Healthcare (NYSE:HCA) within the last quarter: